Bioheart, Inc.
13794 NW 4th Street, Suite 212,
Sunrise, Florida 33325
May 3, 2013
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
Washington, D.C. 20549
Attn: Johnny Gharib, Jeffrey P. Riedler
Re:
Request for acceleration of the effective date of the Registration Statement on Post-Effective Form S-1 of Bioheart, Inc.
Filed April 23, 2013 (amended May 1, 2013)
File No. 333-179096
Mr. Gharib and Mr. Riedler:
Pursuant to requirements of Section 8(a) of the Securities Act the undersigned hereby requests that the Post-Effective Form S-1 Registration Statement of Bioheart, Inc. be declared effective on Tuesday, May 7, 2013 at 4:00PM EST or on such earlier or later date as the Commission acting pursuant to this Section 8(a) shall determine.
Bioheart, Inc. acknowledges that
•
should the Commission or the staff; acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
•
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its fill responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
the company may not assert this action as defence in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
If you have any questions, please call us at 954-835-1500.
Yours truly,
/s/ Mike Tomas
Mike Tomas
Chief Executive Officer
Chief Financial Officer
